tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:AGN Stock Latest News

Argenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Results
Company AnnouncementsArgenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Results
5d ago
AGN
Argenica Therapeutics Unveils Phase 2 Trial Results
PremiumCompany Announcements
Argenica Therapeutics Unveils Phase 2 Trial Results
5d ago
AGN
Argenica Therapeutics Reports Promising Phase 2 Results for Stroke Treatment ARG-007
PremiumCompany Announcements
Argenica Therapeutics Reports Promising Phase 2 Results for Stroke Treatment ARG-007
5d ago
AGN
Argenica Therapeutics Initiates Trading Halt Ahead of Clinical Trial Results
PremiumCompany Announcements
Argenica Therapeutics Initiates Trading Halt Ahead of Clinical Trial Results
7d ago
AGN
Argenica Therapeutics Releases 2025 Corporate Governance Statement
PremiumCompany Announcements
Argenica Therapeutics Releases 2025 Corporate Governance Statement
11d ago
AGN
Argenica Therapeutics Reports Revenue Growth Amid Rising R&D Costs
PremiumCompany AnnouncementsArgenica Therapeutics Reports Revenue Growth Amid Rising R&D Costs
11d ago
AGN
Argenica Therapeutics Addresses FDA’s Clinical Hold on Stroke Treatment
Premium
Company Announcements
Argenica Therapeutics Addresses FDA’s Clinical Hold on Stroke Treatment
25d ago
AGN
Argenica Therapeutics Cautions Investors with New Presentation
Premium
Company Announcements
Argenica Therapeutics Cautions Investors with New Presentation
1M ago
AGN
Argenica Therapeutics Strengthens Regulatory Team with Key Appointment
PremiumCompany Announcements
Argenica Therapeutics Strengthens Regulatory Team with Key Appointment
1M ago
AGN
Insignia Financial Alters Stake in Argenica Therapeutics
PremiumCompany Announcements
Insignia Financial Alters Stake in Argenica Therapeutics
2M ago
AGN
Argenica Therapeutics Advances Stroke Treatment Trials and Secures Funding
PremiumCompany Announcements
Argenica Therapeutics Advances Stroke Treatment Trials and Secures Funding
2M ago
AGN
Argenica Therapeutics Issues New Shares Following Option Exercise
PremiumCompany Announcements
Argenica Therapeutics Issues New Shares Following Option Exercise
2M ago
AGN
Argenica Therapeutics Lists New Securities on ASX
PremiumCompany AnnouncementsArgenica Therapeutics Lists New Securities on ASX
2M ago
AGN
Argenica Therapeutics Announces Cessation of Securities
Premium
Company Announcements
Argenica Therapeutics Announces Cessation of Securities
2M ago
AGN
Argenica Therapeutics Expands ASX Quotation with New Securities
Premium
Company Announcements
Argenica Therapeutics Expands ASX Quotation with New Securities
2M ago
AGN
Argenica Secures $1.5M Funding for Stroke Therapeutic Trials
PremiumCompany Announcements
Argenica Secures $1.5M Funding for Stroke Therapeutic Trials
3M ago
AGN
Argenica Faces FDA Hold on US Stroke Trial Application
PremiumCompany Announcements
Argenica Faces FDA Hold on US Stroke Trial Application
3M ago
AGN
Argenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Progress
PremiumCompany Announcements
Argenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Progress
4M ago
AGN
Argenica Therapeutics Releases Investor Presentation Highlighting Future Plans
PremiumCompany Announcements
Argenica Therapeutics Releases Investor Presentation Highlighting Future Plans
4M ago
AGN
Argenica Therapeutics Advances Phase 2 Trial for Stroke Treatment
PremiumCompany AnnouncementsArgenica Therapeutics Advances Phase 2 Trial for Stroke Treatment
4M ago
AGN
Argenica Completes Dosing in Phase 2 Stroke Trial for ARG-007
Premium
Company Announcements
Argenica Completes Dosing in Phase 2 Stroke Trial for ARG-007
5M ago
AGN
Argenica Therapeutics Announces Cessation of Securities
Premium
Company Announcements
Argenica Therapeutics Announces Cessation of Securities
5M ago
AGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >